GAMMA Investing LLC Sells 738 Shares of Bath & Body Works, Inc. $BBWI

GAMMA Investing LLC decreased its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 16.2% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,823 shares of the company’s stock after selling 738 shares during the period. GAMMA Investing LLC’s holdings in Bath & Body Works were worth $115,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of BBWI. Park Avenue Securities LLC bought a new position in Bath & Body Works in the second quarter valued at about $209,000. UMB Bank n.a. raised its stake in shares of Bath & Body Works by 85.8% in the second quarter. UMB Bank n.a. now owns 2,789 shares of the company’s stock valued at $84,000 after acquiring an additional 1,288 shares during the period. Diversified Trust Co increased its stake in Bath & Body Works by 9.9% in the second quarter. Diversified Trust Co now owns 14,620 shares of the company’s stock worth $438,000 after purchasing an additional 1,311 shares during the period. NorthCrest Asset Manangement LLC purchased a new stake in shares of Bath & Body Works in the 2nd quarter worth $239,000. Finally, Wealth Enhancement Advisory Services LLC increased its holdings in shares of Bath & Body Works by 71.0% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 71,329 shares of the company’s stock valued at $2,364,000 after acquiring an additional 29,618 shares during the period. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Stock Down 0.4%

BBWI stock opened at $25.66 on Thursday. Bath & Body Works, Inc. has a fifty-two week low of $24.93 and a fifty-two week high of $41.87. The company has a 50-day simple moving average of $28.65 and a 200 day simple moving average of $29.53. The company has a market capitalization of $5.29 billion, a P/E ratio of 7.61, a PEG ratio of 0.88 and a beta of 1.52.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting the consensus estimate of $0.37. The company had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The business’s revenue for the quarter was down .8% on a year-over-year basis. During the same quarter last year, the firm posted $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Equities analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were issued a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 3.1%. The ex-dividend date was Friday, August 22nd. Bath & Body Works’s dividend payout ratio (DPR) is 23.74%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Citigroup cut their price objective on Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a report on Tuesday, August 19th. JPMorgan Chase & Co. raised their target price on Bath & Body Works from $40.00 to $46.00 and gave the stock an “overweight” rating in a research note on Monday, July 28th. Wall Street Zen lowered shares of Bath & Body Works from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. UBS Group lowered their price objective on Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating for the company in a research report on Friday, August 29th. Finally, Morgan Stanley lowered their target price on shares of Bath & Body Works from $19.00 to $18.00 and set an “overweight” rating on the stock in a research report on Friday, September 12th. Twelve analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $39.69.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.